https://www.selleckchem.com/pr....oducts/Paclitaxel(Ta
The incidence of adverse events was also comparable regardless of prior BoNTA treatment status. Efficacy and tolerability were similar with DAXI and placebo regardless of prior BoNTA treatment. Assuming an appropriate washout is observed, future BoNTA trials should enroll both treatment-experienced and treatment-naive participants to reflect clinical practice. Efficacy and tolerability were similar with DAXI and placebo regardless of prior BoNTA treatment. Assuming an appropriate washout is observed, future BoNTA trials should
Like
Comment
Share
